{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-022592","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.390580+00:00","generated_at":"2026-05-17T18:20:48.095651+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Calidi Biotherapeutics effects 1-for-12 reverse stock split effective August 4, 2025","bullets":["Reverse stock split at ratio 1-for-12 became effective on August 4, 2025.","No fractional shares issued; rounding up to nearest whole share; authorized shares unchanged at 330M common, 1M preferred.","Stock continues trading under symbol CLDI on NYSE American with new CUSIP 320703408.","Company states reverse split aims to optimize market dynamics and broaden investor appeal.","All outstanding equity awards adjusted proportionally to reflect the reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-022592","json":"https://secwatch.observer/filing/0001641172-25-022592.json","markdown":"https://secwatch.observer/filing/0001641172-25-022592.md","text":"https://secwatch.observer/filing/0001641172-25-022592.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/0001641172-25-022592-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:20:48.095651+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8511827db358cb4966b2ab0bcf1b746a2897de3b","claim":"Calidi Biotherapeutics, Inc.: Approved a 1-for-12 reverse stock split via Certificate of Amendment to the Certificate of Incorporation (effective 2025-08-04).","evidence_excerpt":"The Reverse Stock Split was effected pursuant to the Company’s filing of a Certificate of Amendment (the “Certificate”) with the Secretary of State of the State of Delaware.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225022592/0001641172-25-022592-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-08-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}